News
Hims & Hers Health (HIMS) is quickly becoming one of the most compelling stories in the market as an emerging powerhouse in the direct-to-consumer healthcare space. The stock has posted outsized gains ...
14h
Zacks Investment Research on MSNOuster, Inc. (OUST) Falls More Steeply Than Broader Market: What Investors Need to KnowIn the latest close session, Ouster, Inc. (OUST) was down 4.58% at $23.34. The stock's performance was behind the S&P 500's daily loss of 0.33%. Elsewhere, the Dow lost 0.63%, while the tech-heavy ...
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today July 10th: Canada ...
Here are two stocks with buy rank and strong value characteristics for investors to consider today, July 11th: Scor SCRYY: ...
Detailed price information for Teva Pharmaceutical Industries ADR (TEVA-N) from The Globe and Mail including charting and ...
The Zacks Rank is a short-term stock recommendation of 1 to 3 months which ranks stocks from #1, which is a "Strong Buy", to #5, which is a "Strong Sell".
21h
Zacks.com on MSNFOX vs. NFLX: Which Stock Is the Better Value Option?Investors with an interest in Broadcast Radio and Television stocks have likely encountered both Fox Corporation (FOX) and Netflix (NFLX). But which of these two stocks presents investors with the ...
Using the Zacks Rank to Screen for Value Stocks Combining the power of the Zacks Rank with other fundamentals is a good way to screen for companies with rising earnings estimates.
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results